Source Feed: Global News - Canada
Author: Adriana Fallico
Publication Date: April 2, 2026 - 14:38
Stay informed
Unpublished Opinions
Common antidepressant may help adults with long COVID: study
April 2, 2026
The clinical trial showed a 99 per cent probability that fluvoxamine outperformed placebo for 'reducing fatigue severity and improving quality of life in people with long COVID.'
Police have alleged that Law ran several websites that were used to sell sodium nitrite and other items that can be used for self-harm.
April 18, 2026 - 00:19 | Alessia Simona Maratta | Global News - Ottawa
April 17, 2026 - 21:06 | Matthew Scace, Carrie Tait | The Globe and Mail
April 17, 2026 - 21:00 | Simon Houpt | The Globe and Mail




Comments
Be the first to comment